Acacia, CombiMatrix


Acacia subsidiary CombiMatrix has created what is believed to be the first microarray based on the Severe Acute Respiratory Syndrome coronavirus, the company said.

CombiMatrix said the arrays were fabricated “within 48 hours” of publication of the coronavirus genome sequence believed to be responsible for SARS. Researchers at the US Centers for Disease Control and at the Michael Smith Genome Sciences Center in Canada independently announced early this week that they had sequenced the coronavirus genome.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.